Your browser doesn't support javascript.
loading
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial.
Bonaca, Marc P; Bhatt, Deepak L; Oude Ophuis, Ton; Steg, P Gabriel; Storey, Robert; Cohen, Marc; Kuder, Julia; Im, Kyungah; Magnani, Giulia; Budaj, Andrzej; Theroux, Pierre; Hamm, Christian; Spinar, Jindrich; Kiss, Robert G; Dalby, Anthony J; Medina, Felix A; Kontny, Frederic; Aylward, Philip E; Jensen, Eva C; Held, Peter; Braunwald, Eugene; Sabatine, Marc S.
Afiliación
  • Bonaca MP; TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts.
  • Bhatt DL; TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts.
  • Oude Ophuis T; Department of Cardiology, CWZ Hospital, Nijmegen, the Netherlands.
  • Steg PG; Département Hospitalo Universitaire FIRE, AP-HP, Hôpital Bichat, Paris, France4Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
  • Storey R; Department of Cardiovascular Science, University of Sheffield, Sheffield, England.
  • Cohen M; Cardiovascular Division, Newark Beth Israel Medical Center, Rutgers-New Jersey Medical School, Newark, New Jersey.
  • Kuder J; TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts.
  • Im K; TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts.
  • Magnani G; TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts.
  • Budaj A; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland.
  • Theroux P; Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada.
  • Hamm C; Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany10University of Giessen, Giessen, Hesse, Germany.
  • Spinar J; Internal Cardiology Department, University Hospital and Medical Faculty, Brno, Czech Republic.
  • Kiss RG; Department of Cardiology, Military Hospital, Budapest, Hungary.
  • Dalby AJ; South African Cardiology Clinical Trials Group, Milpark Hospital, Johannesburg, South Africa.
  • Medina FA; Departamento de Clínicas Médicas, Hospital Nacional Cayetano Heredia, San Martin de Porres, Lima, Peru.
  • Kontny F; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.
  • Aylward PE; South Australian Health and Medical Research Institute, Flinders University, Adelaide, Australia.
  • Jensen EC; AstraZeneca Research and Development, Mölndal, Sweden.
  • Held P; AstraZeneca Research and Development, Mölndal, Sweden.
  • Braunwald E; TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts.
  • Sabatine MS; TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts18Deputy Editor, JAMA Cardiology.
JAMA Cardiol ; 1(4): 425-32, 2016 Jul 01.
Article en En | MEDLINE | ID: mdl-27438319
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenosina / Accidente Cerebrovascular / Prevención Secundaria / Infarto del Miocardio Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: JAMA Cardiol Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenosina / Accidente Cerebrovascular / Prevención Secundaria / Infarto del Miocardio Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: JAMA Cardiol Año: 2016 Tipo del documento: Article